Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PATRICIA BERNARD

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1285278523
CMS profile
10732165
Location
ORLANDO, FL

General Payments · PY2023–2024

$383.84

  • Reported across 20 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$290.25

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $290.25 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $77.83 4
Novo Nordisk AS $74.82 3
Lilly USA, LLC $47.35 3
Boehringer Ingelheim Pharmaceuticals, Inc. $31.68 2
Lundbeck LLC $26.02 1
Amgen Inc. $16.69 1
GlaxoSmithKline, LLC. $15.86 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $93.59 5
PY2024 $290.25 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $16.69 05/17/2024 Food and Beverage Undisputed 01/23/2026 1117506323 CMS
AstraZeneca Pharmaceuticals LP $16.08 03/16/2024 Food and Beverage Undisputed 01/23/2026 1104580442 CMS
AstraZeneca Pharmaceuticals LP $20.60 04/04/2024 Food and Beverage Undisputed 01/23/2026 1104746321 CMS
AstraZeneca Pharmaceuticals LP $21.66 04/16/2024 Food and Beverage Undisputed 01/23/2026 1104614030 CMS
AstraZeneca Pharmaceuticals LP $19.49 12/13/2024 Food and Beverage Undisputed 01/23/2026 1104551818 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.14 01/31/2024 Food and Beverage Undisputed 01/23/2026 1117947477 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.54 03/12/2024 Food and Beverage Undisputed 01/23/2026 1117947475 CMS
GlaxoSmithKline, LLC. $15.86 08/05/2024 Food and Beverage Undisputed 01/23/2026 1116331765 CMS
Lilly USA, LLC $13.71 04/12/2024 Food and Beverage Undisputed 01/23/2026 1135923874 CMS
Lilly USA, LLC $18.56 05/13/2024 Food and Beverage Undisputed 01/23/2026 1135923876 CMS
Lilly USA, LLC $15.08 10/16/2024 Food and Beverage Undisputed 01/23/2026 1135898439 CMS
Lundbeck LLC $26.02 05/20/2024 Food and Beverage Undisputed 01/23/2026 1145994323 CMS
Novo Nordisk Inc $22.63 08/14/2024 Food and Beverage Undisputed 01/23/2026 1100385637 CMS
Novo Nordisk Inc $24.88 08/19/2024 Food and Beverage Undisputed 01/23/2026 1100500685 CMS
Novo Nordisk Inc $27.31 10/28/2024 Food and Beverage Undisputed 01/23/2026 1100587331 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.